4SC AG
4SC presents Phase I data on its histone deacetylase HDAC inhibitor 4SC-201 at ASCO
Published in Health Business Week, June 12th, 2009
4SC AG (Frankfurt, Prime Standard: VSC) the German drug discovery and development company, in conjunction with Royal Marsden Hospital in Sutton, England, announced that it will present Phase I data on 4SC-201, an innovative histone deacetylase (HDAC) inhibitor, at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, USA, from May 29 to June 2, 2009. The Phase I data, generated in advanced solid tumors will form the basis of 4SC's drug development program in oncology.
In the Phase I trial, 4SC 201 was orally administered to 18 patients and was applied in therapy cycles, consisting of a once daily oral dose over five consecutive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2009-06-12)
More Articles from Health Business Week
- A. Schulman, Inc.
A. Schulman Appoints Kim L. Whiteman to Head Global Human Resources Team - A. Schulman, Inc.
A. Schulman Expands Sunprene Elastomers Line for Industrial, Specialty Wire & Cable, and Heavy Truck Markets - ABI Research
Wireless Communications Sector Will Reap Huge Benefit from $6.8 Billion Stimulus Bill Funding, Says ABI Research - Abraxis BioScience, Inc.
Marty J. Duvall Joins Abraxis BioScience as Senior Vice President, Global Marketing and International Commercial Operations - Acacia Research Corporation
Acacia Subsidiary Enters into License Agreement with KYRSAGIH BROS. LIMITED LIABILITY COMPANY - Academy of Managed Care Pharmacy AMCP
AMCP Sets Record Straight on Generic Drug Safety - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
